This is the authors' abstract. We don't add key points for this paper.
Xanthine oxidoreductase (XOR) catalyses the reduction of the therapeutic organic nitrate, nitroglycerin (glyceryl trinitrate, GTN), as well as inorganic nitrate and nitrite, to nitric oxide (NO) under hypoxic conditions in the presence of NADH. Generation of nitric oxide is not detectable under normoxic conditions and is inhibited by the molybdenum site-specific inhibitors, oxypurinol and (-)BOF 4272. These enzymic reactions provide a mechanism for generation of NO under hypoxic conditions where nitric oxide synthase does not function, suggesting a vasodilatory role in ischaemia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Millar et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: